Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Private equity | 1 | 33% |
Develops therapeutics for treatment of metastatic pancreatic cancer using combinatorial drug therapy technology
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Private equity | 1 | 33% |